Caveolae regulate vasoconstriction of conduit arteries to angiotensin II in hindlimb unweighted rats

J Physiol. 2015 Oct 15;593(20):4561-74. doi: 10.1113/JP270823. Epub 2015 Sep 10.

Abstract

Weightlessness induces the functional remodelling of arteries, but the changes to angiotensin II (Ang II)-elicited vasoconstriction and the underlying mechanism have never been reported. Caveolae are invaginations of the cell membrane crucial for the contraction of vascular smooth muscle cells, so we investigated the adaptation of Ang II-elicited vasoconstriction to simulated weightlessness and the role of caveolae in it. The 4 week hindlimb unweighted (HU) rat was used to simulate the effects of weightlessness. Ang II-elicited vasoconstriction was measured by isometric force recording. The morphology of caveolae was examined by transmission electron microscope. The binding of the angiotensin II type 1 receptor (AT1 ) and caveolin-1 (cav-1) was examined by coimmunoprecipitation and Western blot. We found that the maximal developing force (E(max)) of Ang II-elicited vasoconstriction was decreased in abdominal aorta by 30.6%, unchanged in thoracic aorta and increased in carotid artery by 17.9% after HU, while EC50 of the response was increased in all three arteries (P < 0.05). AT1 desensitization upon activation was significantly reduced by HU in all three arteries, as was the number of caveolae (P < 0.05). Furthermore, Ang II promoted the binding of AT1 and cav-1 significantly in control but not HU arteries. Both the number of caveolae and the binding of AT1 and cav-1 in HU arteries were restored by cholesterol pretreatment which also reinstated the change in EC50 as well as the level of AT1 desensitization. These results indicate that modified caveolae in vascular smooth muscle cells could interfere with the binding of AT1 and cav-1 mediating the adaptation of Ang II-elicited vasoconstriction to HU.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology*
  • Animals
  • Aorta, Abdominal / drug effects
  • Aorta, Abdominal / physiology*
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / physiology*
  • Carotid Arteries / drug effects
  • Carotid Arteries / physiology*
  • Caveolae / physiology*
  • Caveolin 1 / metabolism
  • Cholesterol / pharmacology
  • Hindlimb
  • Hindlimb Suspension / physiology
  • Male
  • Muscle, Smooth, Vascular / physiology
  • Myocytes, Smooth Muscle / physiology
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1 / metabolism
  • Vasoconstriction / drug effects*
  • Vasoconstriction / physiology
  • Weightlessness

Substances

  • Caveolin 1
  • Receptor, Angiotensin, Type 1
  • Angiotensin II
  • Cholesterol